Inhibition of Platelet Prostaglandin Synthetase by Oral Aspirin

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1978 Feb 1

PMID 413839

Citations 86

Authors

J W Burch

N Stanford

P W MAJERUS

Affiliations

Soon will be listed here.

Abstract

Aspirin inhibits platelet function by permanently acetylating the cyclooxygenase that forms prostaglandins. We determined the sensitivity of platelets to aspirin in normal subjects by measuring [3H-acetyl]aspirin-susceptible cyclooxygenase in washed platelets obtained at various times after aspirin ingestion. A single 325-mg aspirin dose inactivated 89% of platelet cyclooxygenase. The inhibition persisted for 2 days suggesting that oral aspirin also inactivated megakaryocyte cyclooxygenase. Thereafter, active enzyme returned with a time-course reflecting platelet turnover (life-span 8.2+/-2 days). Single doses of 20-650 mg aspirin resulted in 34- greater than 95% inhibition after 24 h. Daily doses of 20-325 mg aspirin for brief periods produced 61- greater than 95% inactivation when measured 24 h after cessation of the drug. Platelet cyclooxygenase is more sensitive to inactivation by aspirin than enzyme in sheep seminal vesicles.

Citing Articles

MAI-TargetFisher: A proteome-wide drug target prediction method synergetically enhanced by artificial intelligence and physical modeling.

Li S, Ren P, Wang L, Han Q, Li F, Li H Acta Pharmacol Sin. 2025; .

PMID: 39870848 DOI: 10.1038/s41401-024-01444-z.

Perioperative Considerations for Hip Arthroplasty in Patients with Rheumatoid Arthritis.

Kim S, Park H, Lee K Hip Pelvis. 2024; 36(4):250-259.

PMID: 39620566 PMC: 11638756. DOI: 10.5371/hp.2024.36.4.250.

Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease.

Patrono C Eur Heart J. 2024; 45(27):2362-2376.

PMID: 38839268 PMC: 11242460. DOI: 10.1093/eurheartj/ehae324.

Fifty years with aspirin and platelets.

Patrono C Br J Pharmacol. 2022; 180(1):25-43.

PMID: 36189951 PMC: 10099789. DOI: 10.1111/bph.15966.

Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

Tosetto A, Rocca B, Petrucci G, Betti S, Soldati D, Rossi E Clin Pharmacol Ther. 2021; 111(4):939-949.

PMID: 34743317 PMC: 9299058. DOI: 10.1002/cpt.2485.

References

Bunting S, Gryglewski R, Moncada S, Vane J . Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976; 12(6):897-913. DOI: 10.1016/0090-6980(76)90125-8. View

Verstraete M . Are agents affecting platelet functions clinically useful?. Am J Med. 1976; 61(6):897-914. DOI: 10.1016/0002-9343(76)90414-9. View

Jafari E, Saleem A, Shaikh B, Demers L . Effect of aspirin on prostaglandin synthesis by human platelets. Prostaglandins. 1976; 12(5):829-35. DOI: 10.1016/0090-6980(76)90056-3. View

Malmsten C, Hamberg M, Svensson J, Samuelsson B . Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci U S A. 1975; 72(4):1446-50. PMC: 432552. DOI: 10.1073/pnas.72.4.1446. View

Shulman N, Watkins Jr S, ITSCOITZ S, Students A . Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans Assoc Am Physicians. 1968; 81:302-13. View

Smith J, Willis A . Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971; 231(25):235-7. DOI: 10.1038/newbio231235a0. View

Collier J, Flower R . Effect of aspirin on human seminal prostaglandins. Lancet. 1971; 2(7729):852-3. DOI: 10.1016/s0140-6736(71)90225-x. View

OBrien J . Effects of salicylates on human platelets. Lancet. 1968; 1(7546):779-83. DOI: 10.1016/s0140-6736(68)92228-9. View

Mustard J . The Gordon Wilson lecture: function of blood platelets and their role in thrombosis. Trans Am Clin Climatol Assoc. 1976; 87:104-27. PMC: 2441384. View

10.

Baenziger N, MAJERUS P . Isolation of human platelets and platelet surface membranes. Methods Enzymol. 1974; 31:149-55. DOI: 10.1016/0076-6879(74)31015-4. View

11.

Elwood P, Cochrane A, Burr M, Sweetnam P, Williams G, Welsby E . A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974; 1(5905):436-40. PMC: 1633246. DOI: 10.1136/bmj.1.5905.436. View

12.

Schwartz A . A method for demonstrating shortened platelet survival utilizing recovery from aspirin effect. J Pediatr. 1974; 84(3):350-4. DOI: 10.1016/s0022-3476(74)80715-8. View

13.

Tollefsen D, FEAGLER J, MAJERUS P . The binding of thrombin to the surface of human platelets. J Biol Chem. 1974; 249(8):2646-51. View

14.

KOCSIS J, Hernandovich J, Silver M, Smith J, Ingerman C . Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins. 1973; 3(2):141-4. DOI: 10.1016/0090-6980(73)90081-6. View

15.

Horton E, Jones R, Marr C . Effects of aspirin on prostaglandin and fructose levels in human semen. J Reprod Fertil. 1973; 33(3):385-92. DOI: 10.1530/jrf.0.0330385. View

16.

WALLACH D, Daniels E . Properties of a novel preparation of prostaglandin synthetase from sheep seminal vesicles. Biochim Biophys Acta. 1971; 231(3):445-57. DOI: 10.1016/0005-2760(71)90112-3. View

17.

Roth G, Stanford N, MAJERUS P . Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975; 72(8):3073-6. PMC: 432922. DOI: 10.1073/pnas.72.8.3073. View

18.

Weiss H . Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis. Am Heart J. 1976; 92(1):86-102. DOI: 10.1016/s0002-8703(76)80408-5. View

19.

Ross R, Glomset J . The pathogenesis of atherosclerosis (second of two parts). N Engl J Med. 1976; 295(8):420-5. DOI: 10.1056/NEJM197608192950805. View

20.

MAJERUS P . Editorial: Why aspirin?. Circulation. 1976; 54(3):357-9. DOI: 10.1161/01.cir.54.3.357. View